Shane Devlin

2.6k total citations · 1 hit paper
64 papers, 1.6k citations indexed

About

Shane Devlin is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Shane Devlin has authored 64 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Genetics, 41 papers in Epidemiology and 17 papers in Surgery. Recurrent topics in Shane Devlin's work include Inflammatory Bowel Disease (45 papers), Microscopic Colitis (32 papers) and Autoimmune and Inflammatory Disorders (13 papers). Shane Devlin is often cited by papers focused on Inflammatory Bowel Disease (45 papers), Microscopic Colitis (32 papers) and Autoimmune and Inflammatory Disorders (13 papers). Shane Devlin collaborates with scholars based in Canada, United States and United Kingdom. Shane Devlin's co-authors include Remo Panaccione, Gilaad G. Kaplan, Gil Melmed, Brian Bressler, Cynthia H. Seow, Christopher N. Andrews, Martin Storr, Jennifer Jones, Corey A. Siegel and Adam S. Cheifetz and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and The American Journal of Gastroenterology.

In The Last Decade

Shane Devlin

62 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Appropriate Therapeutic Drug Monitoring of Biologic Agents for Patients With Inflammatory Bowel Diseases

2019 228 citations Adam S. Cheifetz, Gil Melmed et al. Clinical Gastroenterology and Hepatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shane Devlin Canada	22	1.1k	912	423	363	140	64	1.6k
Jean Frédéric Colombel France	12	1.6k 1.4×	1.2k 1.4×	331 0.8×	690 1.9×	276 2.0×	14	2.2k
Benjamin L. Cohen United States	23	1.1k 1.0×	1.1k 1.2×	189 0.4×	627 1.7×	114 0.8×	123	2.0k
Míriam Mañosa Spain	28	1.5k 1.3×	1.2k 1.3×	348 0.8×	763 2.1×	237 1.7×	129	2.2k
Arthur Barrie United States	24	961 0.9×	813 0.9×	253 0.6×	454 1.3×	85 0.6×	84	1.6k
Arun Swaminath United States	16	667 0.6×	532 0.6×	389 0.9×	475 1.3×	55 0.4×	82	1.3k
Efrat Broide Israel	25	753 0.7×	726 0.8×	200 0.5×	783 2.2×	141 1.0×	117	1.8k
Marte Lie Høivik Norway	21	1.0k 0.9×	1.0k 1.1×	267 0.6×	435 1.2×	71 0.5×	63	1.8k
Jarosław Kierkuś Poland	25	1.4k 1.2×	1.0k 1.1×	815 1.9×	808 2.2×	159 1.1×	186	2.7k
Russell S. Walmsley United Kingdom	14	1.2k 1.1×	963 1.1×	217 0.5×	577 1.6×	112 0.8×	22	2.1k
Wael El‐Matary Canada	28	1.1k 1.0×	907 1.0×	206 0.5×	755 2.1×	166 1.2×	121	2.1k

Countries citing papers authored by Shane Devlin

Since Specialization

Citations

This map shows the geographic impact of Shane Devlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shane Devlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shane Devlin more than expected).

Fields of papers citing papers by Shane Devlin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shane Devlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shane Devlin. The network helps show where Shane Devlin may publish in the future.

Co-authorship network of co-authors of Shane Devlin

This figure shows the co-authorship network connecting the top 25 collaborators of Shane Devlin. A scholar is included among the top collaborators of Shane Devlin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shane Devlin. Shane Devlin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cleveland, Noa Krugliak, Brian Bressler, Corey A. Siegel, et al.. (2022). A Summary of the BRIDGe Summit on Damage-Related Progression of Ulcerative Colitis: Establishing Research Priorities. Gastroenterology. 163(6). 1505–1509. 6 indexed citations

Syal, Gaurav, Miles Sparrow, Fernando Velayos, et al.. (2022). Appropriateness of Medical and Surgical Treatments for Chronic Pouchitis Using RAND/UCLA Appropriateness Methodology. Digestive Diseases and Sciences. 67(10). 4687–4694. 1 indexed citations

Melmed, Gil, Gilaad G. Kaplan, Miles Sparrow, et al.. (2018). Appropriateness of Combination Therapy for Patients With Inflammatory Bowel Diseases: One Size Still Does Not Fit All. Clinical Gastroenterology and Hepatology. 16(11). 1829–1831. 4 indexed citations

Ma, Christopher, Richard N. Fedorak, Gilaad G. Kaplan, et al.. (2017). Clinical, endoscopic and radiographic outcomes with ustekinumab in medically‐refractory Crohn's disease: real world experience from a multicentre cohort. Alimentary Pharmacology & Therapeutics. 45(9). 1232–1243. 123 indexed citations

Melmed, Gil, Peter M. Irving, Jennifer Jones, et al.. (2016). Appropriateness of Testing for Anti–Tumor Necrosis Factor Agent and Antibody Concentrations, and Interpretation of Results. Clinical Gastroenterology and Hepatology. 14(9). 1302–1309. 27 indexed citations

Storr, Martin, Shane Devlin, Gilaad G. Kaplan, Remo Panaccione, & Christopher N. Andrews. (2014). Cannabis Use Provides Symptom Relief in Patients with Inflammatory Bowel Disease but Is Associated with Worse Disease Prognosis in Patients with Crohnʼs Disease. Inflammatory Bowel Diseases. 20(3). 472–480. 155 indexed citations

Devlin, Shane, Brian Bressler, Çharles N. Bernstein, et al.. (2013). Overview of Subsequent Entry Biologics for the Management of Inflammatory Bowel Disease and Canadian Association of Gastroenterology Position Statement on Subsequent Entry Biologics. SHILAP Revista de lepidopterología. 27(10). 567–571. 27 indexed citations

Devlin, Shane, Adam S. Cheifetz, & Corey A. Siegel. (2012). Patient-Specific Approach to Combination Versus Monotherapy with the Use of Antitumor Necrosis Factor α Agents for Inflammatory Bowel Disease. Gastroenterology Clinics of North America. 41(2). 411–428. 6 indexed citations

Cheifetz, Adam S., Gil Melmed, Brennan Spiegel, et al.. (2012). Setting priorities for comparative effectiveness research in inflammatory bowel disease: Results of an international provider survey, expert rand panel, and patient focus groups. Inflammatory Bowel Diseases. 18(12). 2294–2300. 10 indexed citations

10.

Melmed, Gil, Brennan Spiegel, Brian Bressler, et al.. (2010). The Appropriateness of Concomitant Immunomodulators With Anti–Tumor Necrosis Factor Agents for Crohn's Disease: One Size Does Not Fit All. Clinical Gastroenterology and Hepatology. 8(8). 655–659. 39 indexed citations

11.

Silva, Shanika de, Shane Devlin, & Remo Panaccione. (2010). Optimizing the safety of biologic therapy for IBD. Nature Reviews Gastroenterology & Hepatology. 7(2). 93–101. 42 indexed citations

12.

Devlin, Shane & Remo Panaccione. (2009). Evolving Inflammatory Bowel Disease Treatment Paradigms: Top-Down Versus Step-Up. Medical Clinics of North America. 94(1). 1–18. 32 indexed citations

13.

Kaplan, Gilaad G., Remo Panaccione, James Hubbard, et al.. (2009). Inflammatory bowel disease patients who leave hospital against medical advice: Predictors and temporal trends. Inflammatory Bowel Diseases. 15(6). 845–851. 22 indexed citations

14.

Ma, Christopher, Remo Panaccione, Steven J. Heitman, et al.. (2009). Systematic review: the short‐term and long‐term efficacy of adalimumab following discontinuation of infliximab. Alimentary Pharmacology & Therapeutics. 30(10). 977–986. 41 indexed citations

15.

Devlin, Shane & Remo Panaccione. (2009). Evolving Inflammatory Bowel Disease Treatment Paradigms: Top-Down Versus Step-Up. Gastroenterology Clinics of North America. 38(4). 577–594. 22 indexed citations

16.

Sparrow, Miles, Peter M. Irving, Leonard Baidoo, et al.. (2008). Current Controversies in Crohn's Disease: A Roundtable Discussion of the BRIDGe Group.. PubMed Central. 4(10). 713–20. 1 indexed citations

17.

Devlin, Shane & Remo Panaccione. (2008). Adalimumab for the treatment of Crohn's disease. Expert Opinion on Biological Therapy. 8(7). 1011–1019. 24 indexed citations

18.

Devlin, Shane, et al.. (2008). Thiopurine methyltransferase activity combined with 6-thioguanine metabolite levels predicts clinical response to thiopurines in patients with inflammatory bowel disease. Digestive and Liver Disease. 40(6). 425–432. 26 indexed citations

19.

Devlin, Shane, Huiying Yang, Andrew Ippoliti, et al.. (2006). NOD2 Variants and Antibody Response to Microbial Antigens in Crohn’s Disease Patients and Their Unaffected Relatives. Gastroenterology. 132(2). 576–586. 93 indexed citations

20.

Devlin, Shane, Mark G. Swain, Stefan J. Urbanski, & Kelly W. Burak. (2004). Mycophenolate Mofetil for the Treatment of Autoimmune Hepatitis in Patients Refractory to Standard Therapy. SHILAP Revista de lepidopterología. 18(5). 321–326. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact